Key facts
- BARCLAYS PLC filed SCHEDULE 13G/A for IRONWOOD PHARMACEUTICALS INC COMMON-STOCK (IRWD).
- Disclosed ownership: 2%.
- Date of event: 30 Sep 2025.
BARCLAYS PLC - 30 Sep 2025 SCHEDULE 13G/A Report for IRONWOOD PHARMACEUTICALS INC COMMON-STOCK (IRWD)
- Filing Manager
- BARCLAYS PLC
- Reporting Manager
- Barclays PLC
- Symbol
- IRWD
- Shares outstanding
- 162,446,821 shares
- Disclosed Ownership
- 3,167,713 shares
- Ownership
- 2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Nov 2025, 15:34:25 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 12 Aug 2025
- SEC
- View on sec.gov
Key filing fact
BARCLAYS PLC disclosed 2% ownership in IRONWOOD PHARMACEUTICALS INC COMMON-STOCK (IRWD) on 30 Sep 2025.
Change
- Previous schedule filing date: 12 Aug 2025.
- Current filing was accepted on 12 Nov 2025, 15:34.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Barclays PLC | 2% | 3,167,713 | 3,167,713 | 0 | Ramya Rao | Director |
CIK / CUSIP context first